Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

NCT00054197 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: paclitaxel poliglumex
DRUG: vinorelbine tartrate

Sponsor

CTI BioPharma